Gynecologic Oncology

1. Front Matter

   Pages i-xiii

   PDF

2. Fine-needle aspiration cytology in the management of gynecologic oncology patients

   • Lester J. Layfield, Jonathan S. Berek

   Pages 1-13

3. Update on the Bethesda System for reporting cervical/vaginal diagnoses

   • Philip T. Valente

   Pages 15-28

4. The role of human papillomavirus in the genesis of cervical cancer

   • Henry C. Kitchener

   Pages 29-41

5. Oncogene expression in cervical cancer

   • Vicki V. Baker

   Pages 43-51

6. DNA ploidy and S-phase fraction as prognostic factors in cervical cancer

   • Mace L. Rothenberg

   Pages 53-62

7. Neoadjuvant chemotherapy in cervix cancer

   • Peter R. Dottino, Rudy A. Segna

   Pages 63-71

8. The role of intraperitoneal chemotherapy in ovarian cancer

   • Maurie Markman

   Pages 73-82

9. Photodynamic therapy for peritoneal carcinomatosis

   • Zelig A. Tochner

   Pages 83-91

10. Prognostic value of progesterone receptors in endometrial cancer

    • Werner W. Kleine

    Pages 93-100

11. Update on vulvar carcinoma

    • Jacobus van der Velden, Neville F. Hacker

    Pages 101-119

12. Back Matter

    Pages 121-127

    PDF

More often than not, progress in medicine occurs incrementally. The report of an 'important' new observation is typically greeted by a mixture of excitement and skepticism. Yet the true value of the discovery may not be known for several years until it is confirmed (or refuted) by independently conducted studies. In some cases, controversy may continue to shroud a topic due to the discordant results generated by different research groups. Since the last Gynecologic Oncology volume in the Cancer Treatment and Research series, a number of new areas have emerged that shed new light on the pathogenesis, diagnosis, and treatment of gynecologic malignancies. In this volume of the Cancer Treatment and Research series, I have attempted to integrate articles that highlight some of these newest developments with chapters that provide an overview of selected areas of controversy. This volume is not meant to be an abbreviated text of gynecologic oncology but rather a collection of selected works that can provide the reader with a better perspective on the areas of change within the field. The application of molecular biology to cervical cancer has allowed us to understand more completely the roles of human papilloma viruses and cellular oncogenes in the development of cancer of the uterine cervix.

• DNA
• cancer treatment
• carcinoma
• classification
• oncogene
• ovarian cancer
• pathogenesis

• The University of Texas Health Science Center, San Antonio, USA

  Mace L. Rothenberg

Policies and ethics